Reacción #41131

ord-c38d0564c8994c85877cb4441405fdcf

Ecuación de reacción

CC(C)(C)n1ncc(C(=O)NC2C3CC4CC(C3)CC2C4)c1Cl
1-tert-butyl-5-chloro-1H-pyrazole-4-carboxylic acid adamantan-2-ylamide
c1cn[nH]c1
pyrazole
[F-].[K+]
KF
CC(C)(C)n1ncc(C(=O)NC2C3CC4CC(C3)CC2C4)c1-n1cccn1
2′-tert-butyl-2′H-[1,3′]bipyrazolyl-4′-carboxylic acid adamantan-2-ylamide
Rendimiento 41.0%

Disolventes

Condiciones de reacción

Condiciones detalladas
See reaction.notes.procedure_details.

Tratamiento posterior

  1. 1
    OtroThe tube was sealed with a septum
  2. 2
    Otrowas submitted to 150 W microwave irradiation
  3. 3
    Otroa Personal Chemistry Microwave Synthesis system (Biotage AB, Sweden) at 230° C. for 20 minutes
  4. 4
    OtroThe reaction mixture was partitioned between ethyl acetate and water
  5. 5
    Extracciónthe aqueous phase was extracted three times with ethyl acetate
  6. 6
    Concentraciónconcentrated in vacuo
  7. 7
    Otropurified by C-18

Procedimiento

In a Personal Chemistry microwave process tube (Biotage AB, Sweden), 1-tert-butyl-5-chloro-1H-pyrazole-4-carboxylic acid adamantan-2-ylamide (Example 36, 100 mg, 0.30 mmol), pyrazole (41 mg, 0.60 mmol), KF (35 mg, 0.60 mmol) and DMSO (2 mL) were well mixed. The tube was sealed with a septum and was submitted to 150 W microwave irradiation using a Personal Chemistry Microwave Synthesis system (Biotage AB, Sweden) at 230° C. for 20 minutes. The reaction mixture was partitioned between ethyl acetate and water and the aqueous phase was extracted three times with ethyl acetate. The organic phases were combined, concentrated in vacuo and purified by C-18 reversed phase prep-HPLC with a gradient of 10-100% acetonitrile/water to give 2′-tert-butyl-2′H-[1,3′]bipyrazolyl-4′-carboxylic acid adamantan-2-ylamide (45 mg, 41%). Mass spectrum: m/z: 368.2 (M+1).

Fuente

DOI: 10.6084/m9.figshare.5104873.v1Patente: US07728029B2uspto-grants-2010_06